WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2024

Oct 31, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2024-10-29

Reporting Person: Witherspoon Charles (VP & Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-29	Common Stock	M	478	$173.22	Acquired	1956.141	Direct
2024-10-29	Common Stock	S	478	$310.40	Disposed	1478.141	Direct
2024-10-29	Common Stock	S	225	$310.40	Disposed	1253.141	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-29	Stock Options (Right to Buy)	$173.22	M	478	Disposed	2030-02-18	Stock Options (Right to Buy) (478)	Direct

Footnotes

F1: This award vested in four equal annual installments beginning on February 18, 2021.